Enzyme-Enhanced Codelivery of Doxorubicin and Bcl-2 Inhibitor by Electrospun Nanofibers for Synergistic Inhibition of Prostate Cancer Recurrence
One of the great challenges of postoperative prostate cancer management is tumor recurrence. Although postoperative chemotherapy presents benefits to inhibit unexpected recurrence, it is still limited due to the drug resistance or intolerable complications of some patients. Electrospun nanofiber, as...
Saved in:
Main Authors: | Zheng Liu (Author), Xing Luo (Author), Yongxin Mo (Author), Pengkai Zhao (Author), Haixia Wang (Author), Youqiang Fang (Author), Yanteng Xu (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Docetaxel and Doxorubicin Codelivery by Nanocarriers for Synergistic Treatment of Prostate Cancer
by: Ke Li, et al.
Published: (2019) -
Electrospun Nanofibers for Biomedical Applications
Published: (2020) -
Electrospun Nanofibers for Tissue Engineering with Drug Loading and Release
by: Kaiqiang Ye, et al.
Published: (2019) -
Electrospun Composite Nanofibers for Functional Applications
Published: (2022) -
Electrospun Polymer Nanofibers for Food and Health Applications
by: Gizdavic-Nikolaidis, Marija
Published: (2020)